当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析 - 资产负债表

羚锐制药

(600285)

  

流通市值:109.16亿  总市值:109.28亿
流通股本:5.66亿   总股本:5.67亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金743,699,444.82452,893,627.32382,843,943.47459,656,290.81
  交易性金融资产130,308,151.71290,866,573.38160,351,444.44325,723,298.21
  应收票据及应收账款819,993,629.93744,437,344.32597,628,317.71704,418,747.32
  其中:应收票据212,698,322.46193,431,857.39167,227,781.99171,567,007.61
        应收账款607,295,307.47551,005,486.93430,400,535.72532,851,739.71
  应收款项融资57,288,444.16162,259,888.09115,708,095.3169,437,318.67
  预付款项17,949,819.536,062,751.7511,533,941.118,615,493.71
  其他应收款合计14,271,707.0710,823,116.547,100,803.69,914,241.56
  存货359,100,002.25392,614,720.7436,636,298.59407,276,808.11
  一年内到期的非流动资产674,715,734.99453,165,516.66530,300,850.54574,046,406.12
  其他流动资产20,590,107.8623,341,169.9337,784,549.165,017,712.99
  流动资产合计2,837,917,042.292,566,464,708.692,279,888,243.922,574,106,317.5
非流动资产:
  长期股权投资72,598,052.4772,662,921.2972,665,686.5972,933,218.23
  其他权益工具投资42,689,972.18102,437,447.91102,369,163.6463,063,372.79
  其他非流动金融资产124,178,333.02123,550,792.15123,550,792.15132,536,787.4
  投资性房地产2,651,751.68---
  固定资产636,117,092.45645,117,559.99659,178,148.01682,385,860.98
  在建工程65,013,696.5516,956,126.6616,011,118.866,528,114.67
  使用权资产6,019,610.336,704,450.147,433,260.279,054,122.73
  无形资产343,383,573.62324,716,155.08330,142,118.44337,942,323.7
  开发支出15,344,515.6612,215,386.8913,023,083.279,718,952.64
  商誉482,016,236.04482,016,236.04482,016,236.04482,016,236.04
  长期待摊费用4,763,012.285,124,459.585,512,665.525,007,480.34
  递延所得税资产230,411,861.32217,695,279.87198,348,585.87218,784,350.79
  其他非流动资产892,497,648.581,390,023,312.991,345,367,837.681,161,610,587.07
  非流动资产合计2,917,685,356.183,399,220,128.593,355,618,696.343,181,581,407.38
  资产总计5,755,602,398.475,965,684,837.285,635,506,940.265,755,687,724.88
流动负债:
  短期借款361,051,059.43274,632,517.83391,654,678.75516,684,265.92
  应付票据及应付账款92,098,248.44102,583,238.397,273,440.1391,771,131.61
        应付账款92,098,248.44102,583,238.397,273,440.1391,771,131.61
  预收款项474,513.56455,758.51141,637.97129,123
  合同负债66,803,425.2971,876,230.9583,638,642.446,918,741.32
  应付职工薪酬144,007,362.73159,861,530.42159,841,212.95149,257,192.25
  应交税费147,745,179.7135,332,421.0972,608,527.77148,756,735.41
  其他应付款合计1,569,055,874.631,428,557,965.171,295,447,297.241,423,103,855.76
  其中:应付利息194,399.94194,399.94194,399.94194,399.94
  一年内到期的非流动负债1,938,309.431,809,787.122,585,395.812,837,057.71
  其他流动负债24,751,980.4716,115,828.7212,388,619.2314,079,286.63
  流动负债合计2,407,925,953.682,191,225,278.112,115,579,452.252,393,537,389.61
非流动负债:
  租赁负债3,545,781.134,559,885.924,272,081.455,555,023.12
  递延收益35,376,967.436,938,996.0930,999,849.9729,413,862.63
  递延所得税负债38,999,398.5747,635,244.948,741,371.0943,896,132.48
  非流动负债合计77,922,147.189,134,126.9184,013,302.5178,865,018.23
  负债合计2,485,848,100.782,280,359,405.022,199,592,754.762,472,402,407.84
所有者权益(或股东权益):
  实收资本(或股本)567,115,486567,115,486567,115,486567,115,486
  资本公积371,043,752.77369,242,641.54367,202,273.31360,585,741.35
  减:库存股5,600,00012,575,00012,575,00012,575,000
  其他综合收益-10,622,787.5640,320,806.1240,407,787.82,846,678.63
  盈余公积286,212,015.91286,212,015.91286,212,015.91286,252,407.42
  未分配利润2,023,485,406.832,398,554,938.62,152,221,315.872,044,014,416.67
  归属于母公司股东权益合计3,231,633,873.953,648,870,888.173,400,583,878.893,248,239,730.07
  少数股东权益38,120,423.7436,454,544.0935,330,306.6135,045,586.97
  股东权益合计3,269,754,297.693,685,325,432.263,435,914,185.53,283,285,317.04
  负债和股东权益合计5,755,602,398.475,965,684,837.285,635,506,940.265,755,687,724.88
公告日期2026-08-122026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑